The long-awaited implementation of the Markets in Financial Instruments Directive, or MiFID II, on the 3rd of January will alter the face of research. The primary aim of the regulation is to increase overall transparency and efficiency and, by the end of this year, the research market will be forced to change drastically. Joshua Maxey, Managing Director of Third Bridge, explains what the main challenges will be for the sell-side and how the buy side’s choices for research providers will reshape the market.
Have your say. Sign up now to become an Author!